China’s gene sequencing equipment champion seeks public listing amidst sprawling global patent battle

BGI and its sequencer-manufacturing subsidiary MGI Tech made over 70% of their revenue abroad last year, but face over 20 patent assertions in overseas markets

Unlock unlimited access to all IAM content